Low dosage may be behind low efficacy of CureVac vaccine: Study leader

The Straits Times2021-06-17

BERLIN (REUTERS) - The low dosage might be a key reason why CureVac's Covid-19 vaccine reported disappointing efficacy in a pivotal late-stage trial, the scientist leading the study of the shot said ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • Miao94
    2021-06-18
    Miao94
    Sad
  • Lewis1983
    2021-06-18
    Lewis1983
    Sad
  • Ljoney
    2021-06-18
    Ljoney
    Vaccine is the way to go for better normal 
  • Sky0501
    2021-06-18
    Sky0501
    Sad
  • Ezec
    2021-06-18
    Ezec
    Nice 
  • Jyingyang
    2021-06-18
    Jyingyang
    I see. Increase dosage to solve issue ?
Leave a comment
30